Perea, G <br/><br/>
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].  [electronic resource] 

 -  Leukemia  Jan 2006 
 - 87-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2404015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Child<br/>Child, Preschool<br/>Chromosome Inversion<br/>Chromosomes, Human, Pair 16--genetics<br/>Chromosomes, Human, Pair 21--genetics<br/>Chromosomes, Human, Pair 8--genetics<br/>Cytogenetic Analysis<br/>Female<br/>Flow Cytometry<br/>Follow-Up Studies<br/>Humans<br/>Kinetics<br/>Leukemia, Myeloid--genetics<br/>Male<br/>Middle Aged<br/>Neoplasm, Residual--diagnosis<br/>Prognosis<br/>Recurrence<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Risk Factors<br/>Survival Rate